Exclusive: Chan Zuckerberg Initiative announces biohub to build disease-fighting cellular machines

The initiative is the latest program from CZI, a company the couple founded in 2015 to help cure, prevent, or manage all disease by 2100.

October 18, 2023 Check out STAT+

Sponsored By

Photo illustration: Alex Hogan; Source: AP STAT+ | In an unusual arrangement, UnitedHealth's board chair also owns a personal investment firm Experts say the arrangement highlights shortcomings in government disclosure requirements and raises concerns about potential conflicts of interest. By Bob Herman Zuckerberg and Chan announce a New York biohub to build disease-fighting cellular machines To ward off illness like cancer and Alzheimer's, the hub aims to study and emulate how immune cells sense and snuff out cellular fires. By Jason Mast STAT+ | NIH confirmation hearing highlights just how divisive the agency's portfolio has become Monica Bertagnolli, the nominee to lead the NIH, spent her confirmation hearing dodging tough questions from both parties. By Sarah Owermohle Christine Kao/STAT STAT+ | The Ozempic panic: Why a market frenzy over new weight loss drugs defies logic Analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs. By Damian Garde STAT+ | Biotech power broker John Maraganore offers advice to the next crop of entrepreneurs John Maraganore shared thoughts on how entrepreneurs can prepare for the rough-and-tumble world of drug development and raise money. By Jonathan Wosen Wegovy doesn't work for everyone, and no one's quite sure why Let's unpack Wegovy's inconsistent results, BrainStorm Cell Therapeutics' FDA withdrawal, and Nkarta's successful pivot. By Damian Garde STAT STAT+ | In drug development, large pharma companies' staying power provides them an edge, Lilly's chief medical officer says "It's duration of interest, perseverance in a field for decades, which small companies just can't do," Daniel Skovronsky said. By Andrew Joseph Opinion: Listen: Why long Covid might predate the pandemic Steven Phillips and Michelle A. Williams discuss their First Opinion essay "Long Covid is a new name for an old syndrome." By Torie Bosch

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser